Agreements, License Agreement with First Wave Bio, Inc. (Details) - USD ($)			1 Months Ended	12 Months Ended
	Jan. 24, 2021	Jan. 08, 2021	Jan. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
License Agreement [Abstract]
Change in fair value				$ 532,353	$ 0
Series C Preferred Stock [Member]
License Agreement [Abstract]
Aggregate convertible shares of common stock (in shares)				19,140.14
Series C Preferred Stock [Member] | FWB Purchase Agreement [Member]
License Agreement [Abstract]
Conversion price (in dollars per share)		$ 7.50
Aggregate convertible shares of common stock (in shares)		32,902
Stock issued during period (in shares)		3,290.1960
Shares issued, price per share (in dollars per share)		$ 750.00
Deemed dividends on preferred stock issuances		$ 230,000
FWB License Agreement [Member]
License Agreement [Abstract]
Upfront cash payment to be paid in first ten days			$ 9,000,000.0
Upfront cash payment term				10 days
Additional cash to be paid						$ 1,250,000
Amount obligated to pay potential milestone payments				$ 37,000,000.0
Cash consideration					3,000,000.0
Period for conversion of common stock				5 days
Change in fair value	$ 500,000
Difference in fair value of liability initially recorded					$ 3,000,000.0
Fair value	$ 2,500,000
FWB License Agreement [Member] | Convertible Preferred Stock [Member]
License Agreement [Abstract]
Cash consideration				$ 3,000,000.0
Conversion price (in dollars per share)				$ 9.118
Aggregate convertible shares of common stock (in shares)				32,902